
-
Ark Invest's leading ETFs are experiencing huge losses, with individual holdings falling by as much as 93%.
-
The fund's performance has significantly underperformed the broader stock market, and only one of its top 10 holdings is in the green.
-
These are the top 10 losing stocks for the ARK Innovation ETF.
It has been A tough stretch for Cathie Wood and her range of ARK Invest ETFs.
Ark Invest Leading Innovation ETF, Which trades under the stock symbol “ARKK”, It has seen huge losses since its peak in February 2021.
The ARKK ETF is down 72% since its peak on February 19, 2021. Over the same time period, the Nasdaq 100, its underlying index, is up 39% and is holding at record levels. Year to date, the ARKK ETF is down 15% while the Nasdaq 100 is up 12%.
Losses continue to pile up for ARKK, which has $6.3 billion under management. Down from its peak of about $28 billion in assets under management.
according to Data from Cathay ship, A website that tracks the daily trades of ARK Invest's ETFs, only one of the 10 largest stocks ARKK owns — Tesla — has been in the green since it was added to the portfolio. Of the 35 stocks in the portfolio, only seven are positive.
Here are the 10 biggest losers in the ARKK ETF, according to data from Cathie's Ark.
10. Intellia treatments


ARKK Average Cost Basis: $62.04
Current price: $24.67
% changes: -59.9%
9. Epath


ARKK Average Cost Basis: $62.44
Current price: $18.98
% changes: -69.5%
Eighth year


ARKK Average Cost Basis: $243.88
Current price: $56.67
% changes: -77.0%
7. Zoom in on the video


ARKK Average Cost Basis: $278.55
Current price: $63.12
% changes: -77.6%
6. Biological treatments


ARKK Average Cost Basis: $28.17
Current price: $5.25
% changes: -81.0%
5. Unity techniques


ARKK Average Cost Basis: $104.43
Current price: $19.37
% changes: -81.2%
4. 10x Genomics


ARKK Average Cost Basis: $153.19
Current price: $22.67
% changes: -85.0%
3. Pacific Biological Sciences


ARKK Average Cost Basis: $19.84
Current price: $1.88
% changes: -90.2%
2. Thyladoc Health


ARKK Average Cost Basis: $163.91
Current price: $11.43
% changes: -93.0%
1. Ginkgo BioWorks


ARKK Average Cost Basis: $9.99
Current price: $0.66
% changes: -93.4%
Read the original article on Interested in trade
The post Stocks held by ARK Invest’s flagship innovation fund have seen huge losses. Here are the fund’s 10 biggest losers. first appeared on Investorempires.com.